Feedback Plc released its AGM statement

  • November 18, 2019 12:35 PM GMT
  • Team Kalkine
  • Its medical communications application, Bleepa, has made appreciable progress since its launch in September 2019.
  • The company’s TexRAD technology will require to be supported by more clinical data in order to satisfy US FDA.
  • The company has incorporated some modifications into TexRAD research after taking feedback from customers.
  • On 18th November 2019, FDBK shares were trading at GBX 1.05 at GMT 10:52 AM, up 0.03 points or 2.44% from the previous day’s closing price level.


The website is a service of Kalkine Media Ltd (Kalkine Media), Company Number 12643132. The principal purpose of the content on this website is to provide factual information only and does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) or engage in any investment activity under discussion. We are neither licensed nor qualified to provide investment advice through this platform. In providing you with the content on this website, we have not considered your objectives, financial situation or needs. You should make your own enquiries and obtain your own independent advice prior to making any financial decisions.
Some of the images that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed on this website unless stated otherwise. The images that may be used on this website are taken from various sources on the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image. The information provided on the website is in good faith, however Kalkine Media does not make any representation or warranty regarding the content, accuracy, or use of the content on the website.


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK